{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/stroke-tia/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"b322154e-a2d3-59d1-a7b2-d70b4e7812da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field 773a8b2a-7a3e-4aef-b7ec-a7f201892210 --><h2>Evidence exclusion criteria</h2><!-- end field 773a8b2a-7a3e-4aef-b7ec-a7f201892210 -->","summary":null,"htmlStringContent":"<!-- begin item 7f5d040b-3675-4a38-9d46-a7f20187a3cf --><!-- begin field ad0f0ea7-2acb-4b1d-ac16-a7f201892210 --><h2>Our policy</h2><!-- end field ad0f0ea7-2acb-4b1d-ac16-a7f201892210 --><!-- begin field 3afed0c8-5931-464e-ba88-a7f201892210 --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 3afed0c8-5931-464e-ba88-a7f201892210 --><!-- begin field 1e10f380-97f9-4241-b074-a7f201892210 --><h2>Standard exclusions for scoping literature:</h2><!-- end field 1e10f380-97f9-4241-b074-a7f201892210 --><!-- begin field 4e120d13-d035-45a6-b53f-a7f201892210 --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field 4e120d13-d035-45a6-b53f-a7f201892210 --><!-- begin field f076c963-c156-41c8-a7b2-a7f201892210 --><h2>Possible exclusions for reviewed literature:</h2><!-- end field f076c963-c156-41c8-a7b2-a7f201892210 --><!-- begin field 79deb2d0-5faa-4f41-ad21-a7f201892210 --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field 79deb2d0-5faa-4f41-ad21-a7f201892210 --><!-- end item 7f5d040b-3675-4a38-9d46-a7f20187a3cf -->","topic":{"id":"f543bb01-4edc-57a6-ba31-aaa6b6b6e6e8","topicId":"63954e32-591d-4f33-bcbb-3fdecfc69796","topicName":"Stroke and TIA","slug":"stroke-tia","lastRevised":"Last revised in August 2020","chapters":[{"id":"3690cd7d-0a6b-548a-a527-b276c3924bab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aef0c419-4ee2-52b6-b781-c8afa9a11104","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f8baebfc-07d7-5c4a-8d95-4d2bf1f42c38","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3fa3210c-0be8-5167-adb3-6c05aaef00bc","slug":"changes","fullItemName":"Changes"},{"id":"e606f403-4b76-5e30-a38d-6aa4b6e3b4b1","slug":"update","fullItemName":"Update"}]},{"id":"fe337d01-2447-58d3-93e8-a6b09a4920d4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"08277b76-a6c4-566a-a594-131c32067735","slug":"goals","fullItemName":"Goals"},{"id":"acf4fa85-325c-5018-8bc2-9d877522bf6f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"18bc44dc-3e6b-58ae-9d3c-abca76b13c16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4eb59f42-29b3-56e1-993f-1ce8ab7b2969","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"08107877-662b-59e6-a30a-b21e19250f23","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff061807-ab05-5af8-8dd4-01db71526d0f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a0b319c1-8df3-5206-93ce-302f6b981e82","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a0bcd779-defb-50a7-86f6-ab4b2c701ac7","slug":"definition","fullItemName":"Definition"},{"id":"c40d717d-0b67-5cb2-b86c-c67045400115","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"d1569ff2-5da1-51a0-9720-75ad88c0ad86","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ee8fc150-6899-5c75-a0d0-6241055dfd09","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d5730239-5d67-598b-b9d1-f339079de3eb","slug":"complications","fullItemName":"Complications"},{"id":"9b730ca3-d3ee-552b-8145-f6eadf244a63","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"caea5ae7-0be8-5c7c-8bef-7162c7171e9d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"67902a93-a36b-58c6-a67a-3eb89654460c","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"2bc808d1-f905-575d-90b2-8481eb492905","slug":"assessment","fullItemName":"Assessment"},{"id":"6562a8bf-1396-58ba-b1b9-a1914e4adebe","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","fullItemName":"Management","slug":"management","subChapters":[{"id":"1baf2362-0da4-599f-8f9a-12d0124253a0","slug":"suspected-acute-stroke","fullItemName":"Scenario: Suspected acute stroke"},{"id":"15af1682-8287-57f9-90f1-954c1f71792e","slug":"suspected-transient-ischaemic-attack","fullItemName":"Scenario: Suspected transient ischaemic attack"},{"id":"91d820f4-4249-556c-99e2-4ac86d3ebd2a","slug":"secondary-prevention-following-stroke-tia","fullItemName":"Scenario: Secondary prevention following stroke and TIA"},{"id":"84ca3884-d693-5209-b048-6ff53b4ae2be","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Scenario: Management of long term complications of stroke"}]},{"id":"30a83b67-7804-5b41-a647-98d32dce018a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ebfe1dbe-0d9c-5a26-82b4-4d0a308a19ac","slug":"antiplatelet-treatment","fullItemName":"Antiplatelet treatment"}]},{"id":"279444c7-61df-5f92-b512-c703ae6cb9fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8ef8b6ac-1d47-5038-b4d7-4d77faf1a823","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"72590587-c86f-5da1-b397-b7e6cc757702","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7ba85ca6-985e-5af5-b223-0c27f7066797","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b322154e-a2d3-59d1-a7b2-d70b4e7812da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18f7eefe-52bd-5ad8-a39c-b96d270599ff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8fed8545-5194-53a4-b547-2d6a402857f5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"216e65b7-f638-5b35-ad86-30270fbea649","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8ef8b6ac-1d47-5038-b4d7-4d77faf1a823","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}